Cargando…

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma

Carboxylesterase 2 (CES2) is instrumental for conversion of ester-containing prodrugs in cancer treatment. Novel treatment strategies are exceedingly needed for cholangiocarcinoma (CCA) patients. Here, we assessed CES2 expression by immunohistochemistry in a CCA cohort comprising 171 non-liver fluke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goeppert, Benjamin, Renner, Marcus, Singer, Stephan, Albrecht, Thomas, Zhang, Qiangnu, Mehrabi, Arianeb, Pathil, Anita, Springfeld, Christoph, Köhler, Bruno, Rupp, Christian, Weiss, Karl Heinz, Kühl, Anja A., Arsenic, Ruza, Pape, Ulrich Frank, Vogel, Arndt, Schirmacher, Peter, Roessler, Stephanie, Utku, Nalân
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416336/ https://www.ncbi.nlm.nih.gov/pubmed/30867471 http://dx.doi.org/10.1038/s41598-019-40487-9

Ejemplares similares

The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma
por: Albrecht, Thomas, et al.
Publicado: (2021)

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2018)

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies
por: Kriegsmann, Mark, et al.
Publicado: (2019)

Low frequency of mismatch repair deficiency in gallbladder cancer
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
por: Albrecht, Thomas, et al.
Publicado: (2021)

Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer
por: Goeppert, Benjamin, et al.
Publicado: (2015)

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
por: Albrecht, Thomas, et al.
Publicado: (2019)

Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis
por: Charbel, Alphonse, et al.
Publicado: (2022)

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma
por: Goeppert, Benjamin, et al.
Publicado: (2019)

STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma
por: Ploeger, Carolin, et al.
Publicado: (2022)

Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
por: Tóth, Marcell, et al.
Publicado: (2021)

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
por: Tomczak, Aurelie, et al.
Publicado: (2022)

Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study
por: Pape, Ulrich-Frank, et al.
Publicado: (2020)

Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis
por: Goeppert, Benjamin, et al.
Publicado: (2022)

Immunohistochemical analysis of PDK1 expression in breast cancer
por: Arsenic, Ruza
Publicado: (2014)

Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p
por: Goeppert, Benjamin, et al.
Publicado: (2019)

Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma
por: Nickkholgh, A., et al.
Publicado: (2019)

NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis
por: Luiken, Sarah, et al.
Publicado: (2020)

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
por: Neumann, Olaf, et al.
Publicado: (2022)

Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma
por: Andrici, Juliana, et al.
Publicado: (2016)

Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma
por: Wei, Kai, et al.
Publicado: (2019)

An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy
por: Köhler, Bruno Christian, et al.
Publicado: (2018)

Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival
por: Tjaden, Christine, et al.
Publicado: (2023)

Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria
por: Ploeger, Carolin, et al.
Publicado: (2020)

Prognostic Value of Red Blood Cell Distribution Width (RDW) in the Recurrence of Hepatocellular Carcinoma Following Curative Resection
por: Golriz, Mohammad, et al.
Publicado: (2022)

The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
por: Di, Li
Publicado: (2018)

Human carboxylesterases: a comprehensive review
por: Wang, Dandan, et al.
Publicado: (2018)

Small-molecule inhibitors of carboxylesterase Notum
por: Zhao, Yuguang, et al.
Publicado: (2021)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis
por: Billeter, Adrian T., et al.
Publicado: (2020)

Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
por: Vogel, Arndt, et al.
Publicado: (2014)

Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization
por: Su, Jie, et al.
Publicado: (2018)

Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer
por: Drucker, Elisabeth, et al.
Publicado: (2019)

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
por: Wehling, Cyrill, et al.
Publicado: (2021)

Annotation and expression of carboxylesterases in the silkworm, Bombyx mori
por: Yu, Quan-You, et al.
Publicado: (2009)

Carboxylesterases in lipid metabolism: from mouse to human
por: Lian, Jihong, et al.
Publicado: (2017)

Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
por: Goeppert, B, et al.
Publicado: (2013)

Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer
por: Arsenic, Ruza, et al.
Publicado: (2015)

FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?
por: Saborowski, Anna, et al.
Publicado: (2020)

Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy
por: Arsenic, Ruza, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ctun41tmbjv21r1han5ke0h679